Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON20653
NL-OMON20653
Completed
Not Applicable

rsodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and sleeve gastrectomy

Amsterdam UMC, location AMC, Amsterdam, Netherlands0 sites980 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastric bypassbariatric surgerygallstone disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastric bypass
Sponsor
Amsterdam UMC, location AMC, Amsterdam, Netherlands
Enrollment
980
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC, location AMC, Amsterdam, Netherlands

Eligibility Criteria

Inclusion Criteria

  • •Scheduled to undergo Roux\-en\-Y gastric bypass or sleeve gastrectomy for morbid obesity
  • •\- An intact gallbladder

Exclusion Criteria

  • •\- Symptomatic gallstone disease already present before RYGB
  • •\- Prior bariatric surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
rsodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve GastrectomyPrevention of symptomatic gallstone diseaseTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2016-003245-29-NLAmsterdam AMC, locatie AMC980
Active, not recruiting
Not Applicable
Secondary prophylaxis after pancreatitisGallstone DissolutionMedDRA version: 15.1Level: LLTClassification code 10050844Term: Pancreatitis due to gallstonesSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2011-003174-89-ESEnrique De Madaria Pascual
Completed
Phase 4
rsodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.
NL-OMON49056Academisch Medisch Centrum985
Completed
Phase 3
Study of preventive effect of ursodeoxycholic acid on common bile duct stones.Common bile duct stones
JPRN-jRCTs061180077Keishi Kanno21
Recruiting
Phase 3
The protective effect of Ursodeoxycholic Acid in prevention of hepatic damage in neurological patients treated with Sodium Valporat
IRCT20181228042156N1Zabol University of Medical Sciences240